Navigation Links
LA BioMed researcher receives highest honor in field

LOS ANGELES (March 21, 2013) The American Society for Andrology (ASA) is presenting its highest honor, The Distinguished Andrologist Award for 2013, to Christina Wang, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) lead researcher who specializes in the study of male reproductive health and disease, it was announced today.

The organization dedicated to the study of male reproduction will present the award to Dr. Wang during its annual meeting April 13 in San Antonio, TX.

In notifying Dr. Wang of the award, the ASA said she has been on the "front line of andrology in both national and international circles for many years" and had "demonstrated outstanding skills as physician caring for patients with reproductive diseases."

It also noted that Dr. Wang has served as "a role model and mentor for a generation of students, residents and fellows," exhibited leadership by serving in key roles in many professional organizations and led basic and clinical research studies on androgen replacement therapy, hormonal male contraceptive development, diet and androgen metabolism, aging in men and environmental effects on sperm quality that are considered milestone investigations.

ASA, which was founded in 1975 to promote scientific interchange and knowledge of the male reproductive system, said Dr. Wang's research made her a "world leader" in the field.

"Congratulations to Dr. Wang for another well-deserved honor in her stellar career as a tireless researcher, physician, mentor, advocate and administrator," said David I. Meyer, PhD, LA BioMed president and CEO. "She has been incredibly productive, publishing more than 280 peer-reviewed articles and 67 book chapters. LA BioMed is a very proud beneficiary of her energy and her dedication."

Dr. Wang joined LA BioMed in 1993 and currently serves as the associate director of the UCLA-Clinical and Translational Science Institute. She also is a professor of medicine and assistant dean of clinical and translational sciences at the David Geffen School of Medicine at UCLA.

She has served as the World Health Organization's (WHO) chairperson of the Task Force on Methods for the Regulation of Male Fertility and as chair and member of the expert group that edited the last three editions of the WHO Laboratory Manual on semen analyses. She also served as special consultant for the United Nations (UN) for the UN Family Planning Association to review candidate centers, foster high quality research and monitor progress in developing countries.

Dr. Wang has served in various capacities in ASA since 1992, including vice president and president. She also served in various capacities in the International Society of Andrology, including as president from 2009-2013.

In addition, she has served as associate editor of the International Journal of Andrology and on the editorial board of the Journal of Andrology and the Journal of Clinical Endocrinology and Metabolism. Dr. Wang has been invited to give more than 100 lectures worldwide and she has been recognized by her colleagues and institutions with numerous awards, including the ASA Distinguished Service award in 2011.


Contact: Laura Mecoy
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)

Related medicine news :

1. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
2. Biomedical researchers receive Hartwell Foundation awards
3. LA BioMed receives Grand Challenges Explorations grant
4. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
5. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
6. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
7. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
8. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
9. LA BioMed investigator Dr. Christina Wang spearheads study on new male contraceptive gel
10. Louisiana Tech biomedical engineering professor earns recognition, funding for research
11. LA BioMed offers unique educational and research opportunity to local high school seniors
Post Your Comments:
Related Image:
LA BioMed researcher receives highest honor in field
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: